Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy: Clinical Course and Convalescent Plasma Therapy

NCT04884477 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04884477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04884477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy: Clinical Course and Convalescent Plasma Therapy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
January 15, 2023
Enrollment
342 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-cd20 therapy, convalescent plasma, covid-19, immunosuppressed host